Skip to content

Neonatal Spinal Anesthesia: Effects of the Addition of Clonidine

Neonatal Spinal Anesthesia: Effects of the Addition of Clonidine

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01075490
Enrollment
120
Registered
2010-02-25
Start date
2006-11-30
Completion date
2009-12-31
Last updated
2010-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonates, Spinal Anesthesia

Keywords

spinal anesthesia, neonates, clonidine, post operative apnea

Brief summary

This prospective, double blinded study investigates spinal anesthesia with or without clonidine added to bupivacaine in newborns. This study is based on duration measurement of spinal anesthesia and cardio respiratory recording during 24h for apnea detection.

Detailed description

Ex premies and term neonates are two subgroups investigated separately. The overall objective is to validate lengthening of spinal anesthesia in newborns in order to avoid rescue general anesthesia that occur in 20-40 % of patients with plain bupivacaine.

Interventions

DRUGclonidine

addition of 1 µg/kg of clonidine to bupivacaine 1 mg/kg as spinal anesthesia

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 60 Weeks
Healthy volunteers
No

Inclusion criteria

* Newborns less than 60 weeks old post-conceptional, former premature or not * Newborns requiring inguinal hernia or lower limbs surgery, * infants needing no more critical care assistance * Informed consent of parents

Exclusion criteria

* Spinal malformation, * Coagulopathy, * critical hemodynamics, * uncontrolled neurologic or metabolic pathology. * infection at injection point.

Design outcomes

Primary

MeasureTime frame
number of rescue general anesthesiaend of surgery

Secondary

MeasureTime frame
apnea and desaturation occurrenceduring 24h
duration of spinal anesthesiaduring 24h

Countries

France

Contacts

Primary ContactAlain Rochette, MD
a-rochette@chu-montpellier.fr(33)467338256

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026